Latest article
New Knowledge on Section 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro...
BEIJING and BRIDGE WATER, NJ., July 2, 2021 / PRNewswire / - Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan...
